二尖瓣环钙化相关瓣膜功能障碍中跨二尖瓣压差的预后价值
该研究基于2001至2019年机构超声心动图数据库,纳入5754例二尖瓣环钙化(MAC)且平均跨二尖瓣压差(MG)≥3 mmHg的患者,按MG分为低(3-5 mmHg)、中(5-10 mmHg)、高(≥10 mmHg)三组。结果显示MG与全因死亡独立相关(每升高1 mmHg,校正HR 1.064,95%CI 1.049-1.080),合并二尖瓣反流仅在低压差组与死亡相关。
要点
- MAC相关瓣膜功能障碍患者中,平均跨二尖瓣压差升高与全因死亡风险独立相关。
- 合并二尖瓣反流仅在低压差(3-5 mmHg)组与死亡相关,在更高压差组预后价值逐渐减弱。
- 高圧差组1年、5年、10年生存率分别为67%、25%、11%,低于低圧差组。
核心结论
- 在MAC相关二尖瓣功能障碍中,平均跨二尖瓣压差经年龄、性别及MAC相关危险因素校正后仍与死亡率升高相关。
- 合并二尖瓣反流在低圧差范围(3-5 mmHg)与超额死亡相关,但在更高压差时预后重要性逐渐丧失。
研究设计与样本
- 回顾性机构超声心动图数据库研究,纳入2001至2019年MAC且MG≥3 mmHg的患者共5754例。
- 按MG分层:低圧差组(3-5 mmHg,n=3927)、中圧差组(5-10 mmHg,n=1476)、高圧差组(≥10 mmHg,n=351)。
- 平均年龄78±11岁,女性占67%。
- 主要结局为全因死亡,模型校正年龄、性别及MAC相关危险因素(高血压、糖尿病、冠心病、慢性肾脏病)。
主要发现
- 低圧差组1年、5年、10年生存率分别为77%、42%、18%;中圧差组分别为73%、38%、17%;高圧差组分别为67%、25%、11%(组间log-rank P < 0.001)。
- MG与死亡率独立相关(每升高1 mmHg,校正HR 1.064,95%CI 1.049-1.080)。
- 二尖瓣反流严重程度在低圧差组与死亡率相关(P < 0.001),在中圧差组(P = 0.166)和高圧差组(P = 0.372)不相关。
关键数值与推荐
- MG分层界值:低3-5 mmHg、中5-10 mmHg、高≥10 mmHg。
- 二尖瓣反流分布:无/微量32%、轻度42%、中度23%、重度3%。
临床怎么用
- 对MAC相关二尖瓣功能障碍患者,应测量并报告平均跨二尖瓣压差以辅助风险分层。
- 低圧差(3-5 mmHg)合并二尖瓣反流者死亡风险增高,需重点关注。
- 高圧差(≥10 mmHg)患者预后较差,无论二尖瓣反流严重程度如何。
局限性
- 为单中心回顾性超声数据库研究,可能存在选择偏倚。
- 仅纳入MG≥3 mmHg的MAC患者,未涵盖更低压差人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aim of this study was to define the natural history of patients with mitral annular calcification (MAC)-related mitral valve dysfunction and to assess the prognostic importance of mean transmitral pressure gradient (MG) and impact of concomitant mitral regurgitation (MR). METHODS AND RESULTS: The institutional echocardiography database was examined from 2001 to 2019 for all patients with MAC and MG ≥3 mmHg. A total of 5754 patients were stratified by MG in low (3-5 mmHg, n = 3927), mid (5-10 mmHg, n = 1476), and high (≥10 mmHg, n = 351) gradient. The mean age was 78 ± 11 years, and 67% were female. MR was none/trace in 32%, mild in 42%, moderate in 23%, and severe in 3%. Primary outcome was all-cause mortality, and outcome models were adjusted for age, sex, and MAC-related risk factors (hypertension, diabetes, coronary artery disease, chronic kidney disease). Survival at 1, 5, and 10 years was 77%, 42%, and 18% in the low-gradient group; 73%, 38%, and 17% in the mid-gradient group; and 67%, 25%, and 11% in the high-gradient group, respectively (log-rank P < 0.001 between groups). MG was independently associated with mortality (adjusted HR 1.064 per 1 mmHg increase, 95% CI 1.049-1.080). MR severity was associated with mortality at low gradients (P < 0.001) but not at higher gradients (P = 0.166 and 0.372 in the mid- and high-gradient groups, respectively). CONCLUSION: In MAC-related mitral valve dysfunction, mean transmitral gradient is associated with increased mortality after adjustment for age, sex, and MAC-related risk factors. Concomitant MR is associated with excess mortality in low-gradient ranges (3-5 mmHg) but gradually loses prognostic importance at higher gradients, indicating prognostic utility of transmitral gradient in MAC regardless of MR severity.
引用
- Bertrand PB, Churchill TW, Yucel E, et al. Prognostic importance of the transmitral pressure gradient in mitral annular calcification with associated mitral valve dysfunction. Eur Heart J. 2020. PMID: 33221855. doi:10.1093/eurheartj/ehaa819
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。